Inventor
HORVATH ERVIN
DE15 patents
⚠️ This page may combine multiple inventors who share the name “HORVATH ERVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
14 patentsUS6573278B2Jun 3, 2003
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
BAYER AG61 citations95
US6284788B1Sep 4, 2001
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG65 citations95
US6262112B1Jul 17, 2001
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
BAYER AG64 citations95
US6545050B1Apr 8, 2003
Aryl sulphonamide amino acid esters and analogues
BAYER AG30 citations92
US6235774B1May 22, 2001
Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
BAYER AG32 citations91
US6462074B1Oct 8, 2002
Substituted α, β-anellated butyrolactones
BAYER AG17 citations83
US6525087B2Feb 25, 2003
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG10 citations73
US5942529AAug 24, 1999
Benzisothiazolyl-substituted aminomethylchromans
BAYER AG8 citations73
US6331561B2Dec 18, 2001
Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration
BAYER AG9 citations72
US6727279B2Apr 27, 2004
Arylsulphonamides and analogues
BAYER AG3 citations61
US6723718B2Apr 20, 2004
Substituted α, β-anellated butyrolactones
BAYER AG1 citations51
US6433004B1Aug 13, 2002
Substituted β,γ-anellated lactones
BAYER AG1 citations51
US6376539B1Apr 23, 2002
Substituted bicyclic lactones
BAYER AG2 citations51
US6716849B1Apr 6, 2004
Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
BAYER AG1 citations47